Numira Biosciences, Inc. Eyes Break-Even As It Adds $5M To Series A

VentureWire -- Numira Biosciences Inc. has brought its Series A to $7.5 million in a round aimed at taking the specialty contract research company to break-even, the company told VentureWire....